UK: A new study published in The Lancet Respiratory Medicine reports that tezepelumab can significantly reduce the need for oral corticosteroids (OCS) in adults with severe, uncontrolled asthma who ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback